INCY — Incyte Corp. Stock Price, Chart & Financials

INCY

Incyte Corp.Stock · HealthcareS&P 500 0.0%

$117.67+$0.98 (+0.84%)as of market close, Jul 24, 2026

CompareLLYUNHJNJABBVISRGABT

What would $1,000 invested in INCY be worth today? →

INCY returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $117.67
Change YTD: +16.02%
Next earnings: Jul 28, 2026 · Before open
Market cap: 23.5B
Enterprise value: 39.1B
Shares outstanding: 199.8M
52W low: $69.69
52W high: $119.60
From 52W high: -1.61%
From 52W low: +68.85%
52W range: 96%
Beta: 0.76

Volume

Rel volume: 1.05×
30D volume: 1.8M
30D $ vol: 200.5M

Fundamentals

Sales (ttm): 5.4B
Sales/share: $26.83
EPS (ttm): $6.92
FCF (ttm): 1.5B
FCF/share: $7.26
Book value/share: $28.14
Net margin: 26.71%
ROE: 25.46%
ROA: 19.51%
Debt / equity: 3.40×
Current ratio: 3.68

Growth (CAGR, ttm) · 10Y

Sales: +20.11%
Net income: n/a
FCF: +35.73%
Shares: +0.63%

Per-share growth (CAGR, ttm) · 10Y

EPS: +39.97%
Sales/share: +19.36%
FCF/share: +34.87%
Book value/share: +36.94%
Price: +3.13%
Total return: +3.13%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm): 16.4×
Fwd P/E: 13.2×
P/S (ttm): 4.4×
P/B (mrq): 4.2×
P/FCF (ttm): 16.2×
EV/EBITDA (fy): 24.3×
EV/Sales (ttm): 7.3×
FCF yield (ttm): 6.17%
Buyback yield (ttm): 0.00%
Shareholder yield (ttm): 0.00%

Vs own 10Y history

P/E: 14th
P/S: 34th
P/B: 36th
P/FCF: 21st

Bar = where today's multiple sits in INCY's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance

+0.84%

+0.36%

+8.49%

+23.25%

YTD

+16.02%

+66.46%

+50.22%

Financial statements

Open full INCY financials →

Related Healthcare

Ticker	Theme	Price	1M	30D $Vol
LLY Eli Lilly and Company	Pharmaceuticals	$1,196	+7.05%	3.2B
JNJ Johnson & Johnson	Pharmaceuticals	$263	+9.30%	2.1B
ABBV AbbVie Inc.	Biopharma	$259	+10.36%	1.9B
UNH UnitedHealth Group Incorporated Common Stock (DE)		$421	+3.66%	2.6B
MRK Merck & Co. Inc.	Pharmaceuticals	$131	+8.70%	1.3B
TMO Thermo Fisher Scientific Inc.	Life Sciences	$568	+15.45%	1.1B
AMGN Amgen Inc.	Biotech	$376	+7.00%	969.4M
ABT Abbott Laboratories	Medical Devices	$103	+13.95%	1.3B

Incyte Corp. (INCY) trades at $117.67 with a live price and an interactive chart covering 32+ years of daily price history, plus key valuation metrics. ChartRow also publishes INCY's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full INCY financial statements →

INCY — Incyte Corp. stock price, chart and key statistics